Auspex Pharmaceuticals Inc (NASDAQ:ASPX)

70.91
Delayed Data
As of Mar 27
 +2.07 / +3.01%
Today’s Change
14.75
Today|||52-Week Range
88.21
+35.12%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.2B

Company Description

Auspex Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with huntington's disease, an orphan disease, and tardive dyskinesia and tourette syndrome, subsets of either of which may be deemed to be orphan diseases, as well as other orphan indications. The company uses unique properties of deuterium to develop a pipeline of innovative drugs in several important disease areas. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in La Jolla, CA.

Contact Information

Auspex Pharmaceuticals, Inc.
3366 North Torrey Pines Court
La Jolla California 92037
P:(858) 558-2400
Investor Relations:
(858) 875-5896

Employees

Shareholders

Individual stakeholders55.14%
Mutual fund holders26.60%
Other institutional25.98%

Top Executives

Pratik ShahPresident & Chief Executive Officer
Bharat M. ChowriraCOO & Head-Business Development
John P. SchmidChief Financial Officer & Head-Investor Relations
Andreas SommerSecretary & Vice President-Research
David A. StamlerChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account